Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 330331000036119 | aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 40 mg chewable tablet, 20 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 563801000036118 | aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 40 mg chewable tablet, 20 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 40 mg chewable tablet, 20 | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 40 mg chewable tablet, 20 | has MPUU | aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 40 mg chewable tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mylanta 2go Double Strength chewable tablet, 20 | Is a | True | aluminium hydroxide 400 mg + magnesium hydroxide 400 mg + simethicone 40 mg chewable tablet, 20 | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set
FHIR